Medical experts available for March: Colorectal Cancer Awareness, safe sleep & SIDS, returning to sports after injury, sleep aids, and habits to avoid for your brain health

As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…

New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease

New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.

Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States

For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.

New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults

A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.

New Study Shows Adults Treated for Non-Small Cell Lung Cancer Vulnerable to Hazards of Wildfires

New research by scientists at the American Cancer Society and the University of California, San Francisco, shows individuals in the United States undergoing radiotherapy for non-small cell lung cancer who are exposed to wildfires near the treating facility have worse overall survival than unexposed individuals.

New Study Finds Limited Documentation of Cost Discussions With Patients Newly Diagnosed With Advanced Cancer

A new study by researchers at the American Cancer Society and the National Cancer Institute, shows only about a quarter of individuals newly diagnosed with advanced cancers had documented physician discussions about costs of care, which may hinder identifying patient needs and tracking outcomes of referrals for assistance.

New Research Shows Patients Receiving Cancer Treatment Understand Health Insurance Basics; Important Knowledge Gaps Remain

A new study by researchers at the American Cancer Society showed among patients receiving outpatient cancer treatment in two sites, most people could understand basic health insurance terms, such as premiums and deductibles.

Inflammatory Breast Cancer: Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer

Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.

Internationally Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, and University of Maryland Medical Center (UMMC) President and CEO Bert W. O’Malley, MD, announced today that Taofeek K. Owonikoko, MD, PhD, a distinguished physician-scientist with a global reputation in thoracic oncology, has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting

Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.

Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients

Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain

Patients at JFK University Medical Center to Benefit from $1 Million Gift from the Sarala Bathena Foundation

A $1 million gift to Hackensack Meridian JFK University Medical Center Foundation by the Sarala Bathena Foundation will establish the Sarala Bathena Oncology Patient Assistance Fund at Hackensack Meridian JFK University Medical Center, a not-for-profit medical center located in Edison, NJ.

Childhood Cancer Awareness Month Has Special Meaning for Johns Hopkins Children’s Center Pediatric Oncology Nurse

For the past three years, nurse Lauren Chelenza has cared for hundreds of children with cancer while working on the pediatric oncology inpatient unit at Johns Hopkins Children’s Center in Baltimore. It’s a place she never imagined she’d be working 15 years ago, while going through her own cancer treatment.

Colorectal Cancer Patients in Sub-Saharan Africa Receiving Inadequate Care; Survival After Diagnosis Poor, New Study Shows

In new findings led by researchers at the American Cancer Society, Martin-Luther University in Germany, and many other institutes worldwide, fewer than one in 20 patients diagnosed with potentially curable colorectal cancer received standard of care in Sub-Saharan Africa.

September is Prostate Cancer Awareness Month: Know the Warning Signs, When to Get Screened and Important New Treatments

Renowned prostate cancer researcher Dr. Lorelei Mucci is the director of strategic research partnerships at the American Cancer Society. Her role includes leading an ACS initiative called IMPACT, or “Improving Mortality Toward Prostate Cancer Together” to address the alarming negative trends in prostate cancer incidence and disparities. For Prostate Cancer Awareness Month Dr. Mucci reviews the signs and symptoms of prostate cancer, including important information about risk factors, PSA screening, and more.

CureMD Announces Strategic Collaboration with Tempus to Integrate Genomic Testing Functionality in EHR

CureMD, a leading provider of comprehensive technology solutions for community oncology, is proud to announce its partnership with Tempus, a leader in artificial intelligence and precision medicine, to integrate Tempus’ advanced genomic testing capabilities into CureMD’s cutting-edge Electronic Health Record (EHR) system.

Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder

The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.

New Study Shows Substantial Racial and Ethnic Disparities Among Survivors of Second Primary Cancers in the United States

In new findings from researchers at the American Cancer Society, non-Hispanic Black individuals diagnosed with a second primary cancer experienced 21% higher cancer-related death rates and 41% higher cardiovascular-related death rates compared with their non-Hispanic White counterparts.

New Study Shows Black Cancer Survivors Face Increased Mortality From Heart Disease; Neighborhood Socioeconomic Status and Insurance Contributing Factors

A new study from researchers at the American Cancer Society found that Black cancer survivors in the United States experience a higher risk of dying from cardiovascular disease compared with White cancer survivors.

Cancer Research Institute Awards Over $28 Million in Grants to Fuel Immunotherapy Innovations

The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.

New Study Shows Medicaid Expansion Associated With Increase in Palliative Care for Patients With Advanced Cancers

More people with advanced cancers in the United States received critical palliative care services, according to new findings by researchers at the American Cancer Society. Medicaid expansion under the ACA was associated with the largest increases in palliative care use.

Cancer Experts at Jersey Shore University Medical Center Implanting First Targeted Liver Tumor Treatment Pumps in Patients

A team of surgical experts led by Gregory J. Tiesi, M.D., FACS, FSSO, began implanting hepatic artery infusion pumps in patients at Hackensack Meridian Jersey Shore University Medical Center in June. They are among the first in New Jersey to provide the pump for patients.

New Research Shows Increased Medical Debt Associated with Significantly Higher Cancer Mortality Rates

A new study led by researchers at the American Cancer Society found medical debt is associated with significantly higher cancer mortality rates at the county level in the United States. On average, an estimated 20% of the population carried medical debt. For every one percent increase in the population with medical debt, there was a 1.12 increase in death rates (per 100,000 person-years) from cancer. The findings were presented today at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 2-6.

Regular and Increasing Number of Breast Cancer Screenings Improves Survival, New Study Finds

New research led by an international team supported by the American Cancer Society shows women with an increasing number of regular mammography screening exams prior to diagnosis of breast cancer considerably improved their probability of survival. The findings were presented at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 2-6.

CSI Singapore researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has discovered that a transcription factor, TOX2, was aberrantly increased in patients with Natural killer/T-cell lymphoma (NKTL). The increased TOX2 level leads to the growth and spread of NKTL, as well as the overproduction of PRL-3 – an oncogenic phosphatase that is a known key player in the survival and metastasis of several other types of cancers. This breakthrough discovery presents a potential novel therapeutic target to treat NKTL.

New Study Shows Mortality Rates for All Major Cancers Decreasing Globally, Except Liver Cancer in Men and Lung Cancer in Women

A new study conducted by scientists at the American Cancer Society and Brookdale University Hospital Medical Center reveals recent mortality rates for all major cancers decreased in most of the studied countries except lung cancer in females and liver cancer in males, where increasing rates were observed in most countries. The research also showed that cancer-specific mortality rates varied substantially across countries, with rates of lung and cervical cancer varying by 10-fold. The study was published today in the journal Cancer Epidemiology, Biomarkers & Prevention, a publication of the American Association for Cancer Research.